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Abstract Rapid and accurate diagnosis of influenza viruses
plays an important role in infection control, as well as in
preventing the misuse of antibiotics. Isothermal nucleic acid
amplification methods offer significant advantages over the
polymerase chain reaction (PCR), since they are more rapid
and do not require the sophisticated instruments needed for
thermal cycling. We previously described a novel isothermal
nucleic acid amplification method, ‘Strand Invasion Based
Amplification’ (SIBA®), with high analytical sensitivity and
specificity, for the detection of DNA. In this study, we de-
scribe the development of a variant of the SIBA method,
namely, reverse transcription SIBA (RT-SIBA), for the rapid
detection of viral RNA targets. The RT-SIBAmethod includes
a reverse transcriptase enzyme that allows one-step reverse
transcription of RNA to complementary DNA (cDNA) and
simultaneous amplification and detection of the cDNA by
SIBA under isothermal reaction conditions. The RT-SIBA
method was found to be more sensitive than PCR for the
detection of influenza A and B and could detect 100 copies
of influenza RNA within 15 min. The development of RT-
SIBA will enable rapid and accurate diagnosis of viral RNA
targets within point-of-care or central laboratory settings.
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Introduction
Influenza A and B are among the most common causes of
acute human respiratory illness and are associated with high
morbidity and mortality rates in infants, the elderly, and im-
munocompromised individuals (Mallia and Johnston 2007;
Simonsen et al. 2000). Today, patients with influenza infection
may be treated with antiviral drugs; however, these treatments
are only effective when started within the first 2 days of the
illness (Stiver 2003). Thus, timely and accurate diagnosis of
influenza plays an important role in targeting antiviral treat-
ment and, furthermore, has a significant role in the prevention
of the misuse of antibiotics, since the symptoms of influenza
are often similar to those of other respiratory illnesses caused
by bacterial infections (Low 2008).
Nucleic acid amplification tests (NAATs) are becoming the
method of choice for routine diagnosis of influenza and other
respiratory viruses within clinical laboratory settings. NAATs
offer superior sensitivity and specificity over serology, immu-
noassays, and traditional viral culture-based detection
methods (Mahony et al. 2011). Real-time reverse transcription
polymerase chain reaction (RT-PCR) assays have been devel-
oped for the diagnosis of influenza and remain the most com-
mon platform used in NAAT. The RT-PCR method includes,
as a first incubation step, the reverse transcription of RNA to
complementary DNA (cDNA) by a transcriptase enzyme,
followed by a PCR cycling stage. A RT-PCR run is typically
completed within 2 h. Most reverse transcriptases are not ther-
mostable; consequently, the reverse transcription step must be
performed prior to the PCR step (Gerard et al. 2002).
Typically, RT-PCR requires the use of heavy and sophisticated
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thermal cyclers and skilled personnel, which limits its use for
in field or point-of-care applications. In an attempt to address
this drawback, isothermal nucleic acid amplification platforms
have been developed, which do not require the use of heavy,
sophisticated thermal cyclers. Instead, isothermal nucleic acid
amplification methods require only small instruments, en-
abling NAATs to be performed within point-of-care settings.
This has the potential to allow prompt treatment of patients
and limit the inappropriate use of antibiotics and antiviral
drugs.
We previously described a novel isothermal nucleic acid
amplification method, ‘Strand Invasion Based Amplification’
(SIBA®), with high analytical sensitivity and specificity (Hoser
et al. 2014). The method relies on the recombinase-dependent
insertion of a single-stranded invasion oligonucleotide (IO) into
a complementary region of a target duplex DNA, which results
in the dissociation of the target duplex. This dissociation event
generates single-stranded DNA, which in turn allows target-
specific primers to bind and extend the target sequence via the
action of a DNA polymerase. The method was previously found
to be useful for the rapid detection of DNA from pathogens
(Hoser et al. 2014). In this study, we describe the development
of a variant of SIBA technology, namely, reverse transcription
SIBA (RT-SIBA), for the rapid detection of viral RNA targets.
We demonstrate the efficacy of RT-SIBA in the detection of viral
RNA by developing RT-SIBA assays for both influenza A and
B. The assays were designed to detect sequences within con-
served regions of the influenza genome. The RT-SIBA method
includes a reverse transcriptase enzyme that allows a one-step
reverse transcription of RNA to cDNA and simultaneous ampli-
fication and detection of the cDNAwith SIBA under isothermal
reaction conditions. Furthermore, we compared the performance
of RT-SIBA with the previously published Centers for Disease
Control and Prevention (CDC) real-time PCR protocol for the
detection of influenza A and B.
Materials and methods
Oligonucleotides and sample material
The oligonucleotides used in this study were purchased from
Eurofins Genomics (Ebersberg, Germany) or Integrated DNA
Technologies (Leuven, Belgium) and purified by the manu-
facturer using either reverse-phase HPLC (for primers and
probes) or PAGE (for the IOs). Oligonucleotide sequences
are shown in Fig. 1. Amplirun purified and quantified RNA
from influenza A (H1N1, H3N2, and H5N1) and B were
obtained from Vircell (Granada, Spain) and used to determine
the analytical sensitivity of both the RT-SIBA and RT-qPCR
methods. NATtrol FLU Verification Panel (ZeptoMetrix,
Buffalo, NY, USA) samples were used to establish the ability
of RT-SIBA to detect influenza viral particles in the presence
of a simulated clinical sample matrix. Each pathogen was
transferred using nasopharyngeal swabs into a lysis buffer
(10 % Triton X-100, Sigma-Aldrich, USA) and 2 μl was then
added to the reaction.
Transcript and nucleic acid preparation
A 300-bp template sequence containing the region 2023–2322
from the influenza A virus segment 1 polymerase PB2 gene
(KJ942711) was inserted into the pEXA2 vector by a com-
mercial company (Eurofins Genomics, Ebersberg, Germany).
The sequence was flanked by a 20-bp T7 promoter sequence
and a SmaI site at the 5′ and 3′ ends, respectively. Transcripts
were prepared using an in vitro transcription kit (HiScribe™
T7 High Yield RNA Synthesis Kit; New England Biolabs,
Ipswich, MA, USA). Transcripts were quantified both spec-
trophotometrically and by quantitative real-time PCR and
were used to determine the performance and analytical sensi-
tivity of the influenza A RT-SIBA assay.
RT-SIBA influenza A and B assay design
The Influenza Research Database (http://www.fludb.org) was
used to aid the design of the influenza RT-SIBA assays (Squires
et al. 2012). To design an assay for influenza A, a total of 4575
non-duplicate influenza A segment 1 sequences that had been
submitted to the database during the years 2010–2015 were
retrieved and aligned. Special emphasis was put on the most
clinically relevant subtypes, H1N1, H3N2, and H5N1; thus,
sequences representing these subtypes were included in the
alignment. The alignment was analyzed to find areas of limited
variability using Jalview (http://www.jalview.org). A highly
conserved area of approximately 80 nucleotides was identified
at the 3′ end of the aligned segment 1, with a suitable consensus
sequence, and this area was selected as the target area for RT-
SIBA assay design. Analogously, for the influenza B assay, an
alignment of 1495 non-duplicate segment 3 sequences was pro-
duced. A highly conserved, approximately 80 nucleotide area
was identified at the far 5′ end of the alignment and selected as
the assay target area. Alignments of the consensus sequences for
influenza A and B with the oligonucleotides designed for the
SIBA influenza assays are shown in Fig. 1.
In essence, SIBA amplification is highly specific; there-
fore, special care was taken to ensure that the majority of
any sequence variation fell inside the forward or reverse
primers sequences and was limited to a maximum of 1–2
nucleotide changes in the IO region (see Hoser et al. (Hoser
et al. 2014) with respect to general assay design, SIBA spec-
ificity, and initial screening of suitable oligo combinations).
After the assays were established, they were subjected to sev-
eral rounds of optimization as described below.
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RT-SIBA assays
RT-SIBA reactions were performed using a commercial SIBA
reagent kit (Orion Diagnostica Oy, Espoo, Finland) with the
addition of 16 U of GoScript™Reverse Transcriptase (Promega,
Madison, USA). UvsX and gp32 enzymes were each used at
0.25 mg/ml, and the reactions were started using 10 mM mag-
nesium acetate. For the SIBA influenza A assay, the forward and
reverse primers and the IOwere each used at final concentrations
of 400 nM. For the SIBA influenza B assay, the forward and
reverse primers and the IOwere each used at final concentrations
of 200 nM. SIBA amplification was detected using SYBRGreen
1 (dilution, 1:100,000; Thermo Fisher Scientific, USA). RT-
SIBA reactions were incubated at 41 °C for 60 min, and fluores-
cence readings were taken at 60-s intervals on an Agilent MX
Pro 3005P instrument (Agilent Technologies, Inc., CA, USA).
After incubation for 60 min, the instrument was set to run a melt
curve from 40 to 95 °C, to further assess the specificity of the
SIBA reactions.
Optimization of the influenza A and B RT-SIBA assays
SIBA reactions were optimized for the rapid detection of influ-
enza A by first determining the best nucleotide configuration
for the IO to give the shortest detection time. This was achieved
by varying the length and composition of the 5′ non-
homologous (seeding) region of the IO. Six different IOs with
seeding regions of lengths varying from 0 to 17 nucleotides
were tested. In another approach, the length of the seeding
region was maintained at ten nucleotides but the nucleotide
composition of the seeding region was modified to contain
either polyC, polyT, polyA, polyG, poly purines, or poly py-
rimidines. The exact sequences of each tested IO are listed in
Table S1. The performance of each IO at 200 nM was assessed
by its ability to facilitate amplification of 10,000 copies of in
vitro transcribed influenza A RNA in the presence of the
primers. The best performing seeding region was then chosen
for subsequent SIBA influenza A experiments and adopted for
influenza B SIBA assay design.
Real-time RT-PCR
The performance of RT-SIBA assays for the detection of in-
fluenza A and B was compared with the CDC protocol for
real-time RT-PCR of influenza A and B ((WHO) 30 April
2009; Selvaraju and Selvarangan 2010). Briefly, the RT-PCR
reactions were performed with the EXPRESS One-Step
SuperScript® qRT-PCR SuperMix Kit, with ROX Reference
Dye (Thermo Fisher Scientific, USA). This kit contains a
heat-labile form of uracil DNA glycosylase (UDG), in addi-
tion to SuperScript® III Reverse Transcriptase and Platinum®
Taq DNA polymerase, in order to prevent any potential carry-
over contamination. The reactions were detected using an
Applied Biosystems 7500 PCR instrument (Thermo Fisher
Scientific, USA). All primers and probes were used at 1 μM
and 200 nM, respectively. The following thermal cycling pro-
tocol was used: 50 °C for 30 min (cDNA synthesis), 95 °C for
2min (reverse transcription andUDG inactivation), and 45 cy-
cles of 95 °C for 15 s and 55 °C for 30 s (PCR amplification).
Results
Assay optimization to minimize detection time
The mechanism of RT-SIBA is described in Fig. 2. The IO, used
in SIBA reactions to separate the target duplex DNA, includes a
5′ region that is not homologous to the target sequence. This non-
homologous region, termed the seeding region, is included in the
IO to allow for optimal coating of the homologous portion by the
recombinase. The affinity of the recombinase for DNA mole-
cules was previously suggested to be dependent on both the
length and nucleotide composition of the target molecule
(Formosa and Alberts 1986). Therefore, we hypothesized that
the length and composition of the seeding region could also
impact the speed of SIBA assays. In order to test our hypothesis,
SIBA influenza A assay IOs containing seeding regions that
differed in length and nucleotide composition were designed
and tested, and the results are depicted in Fig. 3. The use of an
Influenza A assay
Cons-A   5'   ACTAATTGATGGCCATCCGAATTCTTTTGGTCGCTGTCTGGCTGTCAGTAAGTATGCTAGAGTCCCGTTTTCGT        3'
IO-A     5'    CCCCCCCCCCCCGAATTCTTTTGGTCGCTGTCTGGCTGTCAGUAAGUAUGC 3'
IFA-F    5'   AATTGATGGCCATCCGAATT 3'
IFA-R    3'                                                        TACGATCTCAGGGCAA 5'
Influenza B assay
Cons-B   5'   TCCAGACTACAATAATACAAAAGGCCAAAAACACAATGGCAGAATTTAGTGAAGATCCTGAATTACAACCAGCAATGCT   3'
IO-B     5'         CCCCCCCCCCCCCCAAGGCCAAAAACACAATGGCAGAATTTAGUGAAGAUCCUGA 3'
IFB-F    5'        ACTACAATAATACAAAAG 3'
IFB-R    3'                                                           GGACTTAATGTTGGTCGT        5'
Fig. 1 Alignment of oligonucleotides with consensus sequences. Italic
sequence denotes 2′-O-methyl RNA sequence present in invasion
oligonucleotides. Bold poly-cytosine denotes the non-homologous
seeding area present in invasion oligonucleotides. Underlined sequence
denotes the overlap between the forward or reverse primers and their
respective invasion oligonucleotides
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IO with no seeding region resulted in reactions with the longest
detection time, suggesting that the seeding region is of vital im-
portance for efficient amplification of the target DNA.
Furthermore, shorter detection times were observed as the length
of the seeding region increased. Our experiments demonstrate
that the optimal length of the seeding region, in terms of assay
speed, is aminimumof six nucleotides. To evaluate the impact of
the nucleotide composition of the seeding region on assay speed,
seven IOs with seeding regions containing either polyC, polyT,
polyA, polyG, poly purines, poly pyrimidines, or mixed nucleo-
tides were tested. The use of IO seeding regions containing
polyC and polyT resulted in the shortest detection times, while
the use of an IO containing a polyG seeding region led to the
longest detection time. The IO containing a seeding regionwith a
mixture of pyrimidine nucleotides was found to display shorter
detection times than that with a mixture of purine nucleotides. In
Fig. 2 aMechanistic description
of the RT-SIBA reaction. 1 RNA
is reverse transcribed to cDNA by
the transcriptase enzyme. 2 The
SIBA reaction requires two target-
specific primers and an invasion
oligonucleotide (IO). All single-
stranded elements are coated with
gp32. 3 T4 UvsX recombinase
polymerizes the IO displacing
bound gp32. The lengths of the
primers used are too short to act as
substrates for UvsX. 4 IO invades
the complementary region of the
target duplex through the activity
of UvsX. The invasion process
facilitates the complete separation
of the target duplex, allowing
target-specific primers to bind the
target. 5 The strand displacement
polymerase is able to extend the
dissociated target duplex from the
primers. This event leads to the
production of two copies of the
target duplex. The recombinase-
mediated target duplex separation
and polymerase-mediated
extension are the basis for
exponential amplification
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conclusion, IOs for both influenza A and B assays used in the
following experiments were designed to contain seeding regions
consisting of a polyC sequence of 10 and 14 nucleotides in
length, respectively.
Sensitivity and inclusivity of influenza A and B RT-SIBA
assays in comparison with RT-PCR
The sensitivities of both the influenza A and B RT-SIBA
assays were assessed against those of the equivalent previ-
ously published CDC real-time RT-PCR assays. Serial di-
lutions of quantified Amplirun RNA controls for influenza
A H1N1, H3N2, and H5N1 subtypes, as well as influenza
B, were used as templates for both RT-SIBA and RT-PCR
assays. Quadruplicate reactions were performed in at least
three independent experiments. The diluted samples were
analyzed simultaneously with both RT-SIBA and RT-PCR
reactions in order to facilitate comparison between the two
methods. The results are shown in Fig. 4 and Table 1.
RT-SIBA reliably detected as low as ten copies of viral
RNA per reaction. Serial dilutions from 1000 to 10 copies
of purified RNA from different influenza subtypes showed
reproducible and specific amplification when detected
using SYBR green I fluorescent dye. Post-amplification
melt curve analysis was performed after each run, and am-
plification of a single-specific amplicon was detected for
both influenza A and B assays (data not shown).
Furthermore, the influenza A RT-SIBA assay did not am-
plify influenza B RNA or vice versa.
Comparison of analytical sensitivity in terms of RNA
copy numbers per reaction indicated that the RT-SIBA
assays had comparable or superior sensitivity, compared
with RT-PCR assays (Table 1). Notably, we were able to
demonstrate the sensitivity of RT-SIBA to be ten copies of
target RNA per reaction for both influenza A and B as-
says; however, our experiments demonstrated that, unlike
that of the RT-SIBA assays, the sensitivity of RT-PCR
varied depending on the assay and influenza template subtype
used. For influenza B assays, RT-SIBA and RT-PCR assays
Fig. 3 The impact of changes to
the invasion oligonucleotide (IO)
seeding region nucleotide
composition on the average
detection time for the SIBA
influenza A assay. The impact of
the seeding region a length and b
composition (for a ten nucleotide
seeding region). The results are
presented as the average detection
time from eight replicate assays
(standard deviation included). The
detection time reported was the
time at which the probe fluorescent
signal exceeded the background
signal
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performed equally well and were both able to successfully
amplify ten copies of RNA per reaction. However, a sig-
nificant difference between RT-SIBA and RT-PCR was ob-
served for the influenza A assays. Ten copies of all tested
subtypes of influenza A were reproducibly amplified and
detected by RT-SIBA, whereas the RT-PCR assay was only























































































































Fig. 4 Sensitivity and inclusivity of influenza A and B RT-SIBA assays.
Serial dilutions of RNA from different influenza serotypes were prepared
and used as templates in RT-SIBA assays. The reactions were run in
quadruplicate in three individual experiments. The figures show data
from one experiment, and the data are plotted as the average of four
replicate reactions. The total copy number of template RNA per
reaction was 10–1000 copies/reaction. The results indicated that RT-
SIBA could be used to reproducibly detect as few as ten copies of
influenza RNA per reaction. NTC = no template control
Table 1 Sensitivity of the
influenza A and B RT-SIBA
assays, compared with equivalent
CDC RT-PCR assays
No. of positive reactions (average time to positive result*)
RT-SIBA RT-PCR
Subtype Copies/reaction Influenza A Influenza B CDC-A CDC-B
A (H1N1) 1000 12/12 (12 min) 12/12 (54 min)
100 12/12 (15 min) 0/12
10 12/12 (20 min) 0/12
A (H3N2) 1000 12/12 (11 min) 12/12 (50 min)
100 12/12 (14 min) 12/12 (52 min)
10 12/12 (16 min) 0/12
A (H5N1) 1000 12/12 (10 min) 12/12 (51 min)
100 12/12 (12 min) 12/12 (53 min)
10 12/12 (15 min) 0/12
B 1000 12/12 (10 min) 12/12 (51 min)
100 12/12 (12 min) 12/12 (53 min)
10 11/12 (13 min) 11/12 (56 min)
*Ramp time of RT-PCR reactions not included in the calculations
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The average time to achievement of a positive reaction,
corresponding to the threshold cycle (Ct)-value for RT-
PCR reactions, was calculated according to the one-step
RT-PCR cycling program, without taking into account the
ramping time needed for PCR cycling. RT-SIBA reactions
were performed at a constant temperature, and data were
collected at 1 min intervals. Therefore, the Ct-values of
RT-SIBA reactions corresponded directly to the time re-
quired to achieve a positive result. The average times to
positive results for both RT-SIBA and RT-PCR reactions
are listed in Table 1.
Positive results from 100 copies of influenza B RNA tem-
plate per reaction were obtained in an average of 12 min with
the RT-SIBA assay, whereas an average of 53 min was re-
quired to yield a positive result by RT-PCR. Similarly, 100
copies of influenza A H1N1, H3N2, and H5N1 subtypes were
detected by RT-SIBA in 15, 14, and 12 min, respectively,
whereas reaction times of more than 50 min were needed for
RT-PCR. These results demonstrate a major advantage of RT-
SIBA over RT-PCR.
Analytical specificity of RT-SIBA influenza A and B
assays and their performance in analysis of a clinical panel
The specificities of the SIBA influenza A and B assays
were elucidated by challenging the reactions with nucleic
acid from six other common human respiratory pathogens.
These included human rhinovirus, respiratory syncytial
virus (RSV), coronavirus, adenovirus, staphylococcus
aureus, and streptococcus pyogenes. All non-influenza
nucleic acid templates gave negative results with both the
influenza A and B RT-SIBA assays (data not shown). The
influenza A assay was further challenged with an influenza
B RNA template, which was not detected by the assay.
Similarly, the influenza B assay did not detect influenza
A template RNA. These findings suggest that both of the
SIBA influenza assays are specific for their respective
targets.
The performance of both the influenza A and B RT-SIBA
assays was further evaluated using commercial NATtrol FLU
verification panel samples that contain viral or bacterial parti-
cles in a protein matrix, to mimic clinical specimen samples.
The panel consisted of six influenza A virus H1 and H3
strains, two influenza B strains, respiratory syncytial virus
A, respiratory syncytial virus B, rhinovirus 1 A, parainfluenza
virus type 1, Echovirus Type 30, Coxsackievirus type A9,
Mycoplasma pneumoniae strain M129, and Neisseria
meningitidis Serogroup A. The results are shown in Table 2.
The influenza A RT-SIBA assay detected all six influenza A
strains and did not cross-react with influenza B strains, nor the
other respiratory pathogens. Similarly, the influenza B RT-
SIBA assay detected the two influenza B strains and did not
cross-react with influenza A strains, nor the other respiratory
pathogens. This indicates that the influenza A and B RT-SIBA
assays are likely to be suitable for detecting influenza viruses
from clinical specimens.
Table 2 NATtrol FLU




Influenza A H1N1 A/NewCaledonia/20/
99
19.4 –
Influenza A H1N1 A/Brisbane/59/07 20.1 –
Influenza A H3N2 A/Brisbane/10/07 17.4 –
Influenza A H3N2 A/Wisconsin/67/05 18.4 –
Influenza A 2009 H1N1 Canada/6294/09 18.6 –
Influenza A 2009 H1N1 NY/02/09 19.9 –
Influenza B B/Florida/02/06 – 14.8







Rhinovirus 1 A NA – –
Parainfluenza virus type 1 NA – –
Echovirus Type 30 NA – –
Coxsackievirus type A9 NA – –
M. pneumoniae M129 – –
N. meningitidis Serogroup A NA – –
Time to detection (in minutes) of positive reactions is shown in the table. Data represent averages of five replicates
from one representative run. The number of viral particles per sample was not reported by the manufacturer
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Discussion
In this study, we demonstrated the ability of SIBA technology
to detect RNA-pathogens, RT-SIBA, for the rapid detection of
influenza A and B with high analytical sensitivity and speci-
ficity. Previously, it was demonstrated that SIBA technology
is a feasible method for the reliable detection of DNA from
pathogenic micro-organisms (Hoser et al. 2014). In this paper,
we demonstrate that RT-SIBA can be applied for the rapid
detection of pathogens that have RNA, rather than DNA, as
their genetic material, as is the case for the majority of viruses.
The method described here includes a reverse transcriptase
enzyme in the same reaction tubes as the other SIBA reaction
components required for nucleic acid amplification and con-
sequently permits a one-step reverse transcription of RNA to
cDNA and simultaneous amplification and real-time detection
of cDNA by SIBA.
The SIBA method consists of a recombinase, required for
homologous recombination, an IO, which is a substrate for the
recombinase, and two target-specific primers that are not sub-
strates for the recombinase. The IO separates the target duplex,
with the aid of the recombinase, consequently allowing the
primers to bind and extend the target via the action of a DNA
polymerase. Repeated cycles of duplex separation and primer
extension are the basis for exponential amplification. In this
report, the amplification times for the SIBA influenza assays
were first optimized by varying the length and composition of
the IO non-homologous region (i.e., the seeding region). Our
experiments showed that a polyC or polyT non-homologous IO
region of at least ten nucleotides in length resulted in the
shortest detection times. The recombinase, UvsX binds prefer-
entially to pyrimidine rich nucleotides (Formosa and Alberts
1986), however, the reaction demands both the binding and
release of the recombinase and consequently the optimal con-
figuration of the seeding region was determined empirically.
The necessity of the seeding region demonstrated that the
recombinase perform less efficiently at the initial potential bind-
ing sites prior to its polymerization from 5′-3′.
The average times to detection for both the influenza A and
B RT-SIBA assays were below 15min for 100 copies of RNA.
Thus, the complete test can be conducted in less than 30 min.
This is significantly faster than the real-time RT-PCR method,
which took over 1 h for the detection of influenza. In RT-SIBA,
the reverse transcription and cDNA amplification occur simul-
taneously and at the same reaction temperature, thus facilitating
rapid detection of target RNA. By contrast, in real-time RT-
PCR, reverse transcription requires an initial incubation period
of 30 min at a constant temperature prior to the repeated PCR
cycles of denaturation, annealing, and elongation, resulting in a
total run time of 90–120min. Furthermore, RT-SIBAwas found
to be more sensitive than RT-PCR for the detection of influenza
A and B. RT-SIBA displayed a 100-fold improvement in sen-
sitivity, compared with RT-PCR, for the detection for H1N1.
The SIBA reaction components include the single strand bind-
ing protein, gp32, which acts as a recombinase accessory pro-
tein and is required for the removal of secondary structures
within the oligonucleotides used in the assay. It is possible that
the presence of gp32 in the RT-SIBA reaction mixture could
also contribute to the high analytical sensitivity displayed by
RT-SIBA for RNA targets. This is supported by previous stud-
ies, which showed that single binding proteins enhance the
yield of cDNA synthesis by reverse transcriptase, thus improv-
ing DNA amplification sensitivity (Jefferies and Farquharson
2002; Villalva et al. 2001). Furthermore, the difference in RT
enzymes used in RT-SIBA and RT-PCR could account for the
significant difference in sensitivity between the methods.
Several studies show that commercially available reverse tran-
scriptases display varying performance regarding cDNA yield
and sensitivity (Levesque-Sergerie et al. 2007; Okello et al.
2010; Ståhlberg et al. 2004).
The performance of RT-SIBA for the detection of influenza A
and B was determined using the commercially available clinical
NATtrol FLU verification panel samples, which simulate clinical
specimen samples. The RT-SIBA influenza assays amplified the
influenza specimens specifically, with no cross-reactions with
other respiratory pathogens. Since RT-SIBAwas found to be less
susceptible to sample derived inhibition, the method does not
require highly purified RNA template material and crude disrup-
tion of viral particles using detergents was found to be sufficient.
The sensitive and rapid detection of influenza viruses within
15 min, as well as the tolerance to sample derived inhibition,
demonstrate that these assays are powerful molecular diagnostics
tools. Since the method is performed at a low and constant tem-
perature, there is potential for it to be run using battery operated
and portable devices of considerably lower complexity than
those used for RT-PCR. Isothermal methods can reasonably be
expected to extend the use of molecular methods outside of
centralized laboratory spaces into lower complexity settings,
such as smaller laboratories, the field, or even domestic homes.
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